Adicet Bio, Inc. Operating Lease, Liability, Current
Adicet Bio, Inc. (ACET) had Operating Lease, Liability, Current of $2.65 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-05
- 2026-06-30: Operating Lease, Liability, Current $2.65M.
- 2026-03-31: Operating Lease, Liability, Current $2.75M.
- 2025-12-31: Operating Lease, Liability, Current $2.84M.
- 2025-09-30: Operating Lease, Liability, Current $2.92M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $2.65M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $2.75M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $2.84M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $2.92M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.95M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.98M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $3.13M 10-K · filed 2026-03-12 |
| 2024-09-30 | $3.28M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $3.42M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $3.32M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $3.22M 10-K · filed 2025-03-06 |
| 2023-09-30 | $3.13M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $3.04M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.95M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.49M 10-K · filed 2024-03-19 |
| 2022-09-30 | $2.41M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $2.26M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $1.73M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.57M 10-K · filed 2023-03-15 |
| 2021-09-30 | $712.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.05M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.25M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.22M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |